Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 9, 2003
The drug budget silo mentality in Europe: an overview
Lou Garrison, Adrian Towse
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties
Adrian Towse, Elisabeth Fenwick
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 5, 2002
The economics of gene therapy and of pharmacogenetics
Patricia Danzon, Adrian Towse
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 18, 2014
Orphan drugs policies: a suitable case for treatment
Michael Drummond, Adrian Towse
Frontiers in Health Services
|
March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
Bernarda Zamora, Adrian Towse
The Health Service Journal
|
September 10, 2008
A perfect 10 from patients the number one target
Jon Sussex, Adrian Towse
Bulletin of the World Health Organization
|
May 4, 2005
Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policies
Adrian Towse, Hannah Kettler
International Journal of Technology Assessment in Health Care
|
December 3, 2013
Approaches to identifying, measuring, and aggregating elements of value
Adrian Towse, Paul Barnsley
Journal of Managed Care & Specialty Pharmacy
|
September 27, 2019
A Strategy to Support Efficient Development and Use of Innovations in Personalized Medicine and Precision Medicine
Louis P Garrison, Adrian Towse
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers?
Diego F Ossa, Adrian Towse
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 9, 2003
The drug budget silo mentality in Europe: an overview
Lou Garrison, Adrian Towse
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties
Adrian Towse, Elisabeth Fenwick
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 5, 2002
The economics of gene therapy and of pharmacogenetics
Patricia Danzon, Adrian Towse
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 18, 2014
Orphan drugs policies: a suitable case for treatment
Michael Drummond, Adrian Towse
Frontiers in Health Services
|
March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
Bernarda Zamora, Adrian Towse
The Health Service Journal
|
September 10, 2008
A perfect 10 from patients the number one target
Jon Sussex, Adrian Towse
Bulletin of the World Health Organization
|
May 4, 2005
Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policies
Adrian Towse, Hannah Kettler
International Journal of Technology Assessment in Health Care
|
December 3, 2013
Approaches to identifying, measuring, and aggregating elements of value
Adrian Towse, Paul Barnsley
Journal of Managed Care & Specialty Pharmacy
|
September 27, 2019
A Strategy to Support Efficient Development and Use of Innovations in Personalized Medicine and Precision Medicine
Louis P Garrison, Adrian Towse
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers?
Diego F Ossa, Adrian Towse
Page
of 10